A global clinical trial involving The Hospital for Sick Children (SickKids) has found that mavacamten—a heart medication ...

Patients with rheumatic heart disease who took the heart failure drug digoxin were 18% less likely to die or experience ...

A drug used to help patients lose weight and manage diabetes may also help those with heart failure, an international clinical trial shows. The test of tirzepatide, brand named Zepbound, included 731 ...

Weight-loss and diabetes drug tirzepatide can reduce the risk of death or worsening heart failure for patients with obesity and heart failure with preserved pump function, new research reveals. Weight ...

Heart failure has increasingly been recognized as a complex, metabolism-driven syndrome that extends far beyond traditional models of hemodynamic ...

Share on Pinterest Weight loss drugs could help improve health outcomes in people with heart failure. The Good Brigade/Getty Images Researchers report that the weight loss drugs semaglutide and ...

CHICAGO — ­New clinical trial results on the diabetes and obesity drug tirzepatide have doctors buzzing about its potential to treat heart failure, keep weight off and prevent type 2 diabetes. One of ...

Studies have demonstrated that DNA damage plays a critical role in the development of pressure overload–induced heart failure, dilated cardiomyopathy and aging-related cardiac conditions, and this ...

How would you summarize your study for a lay audience? Heart failure remains a substantial burden for patients due to its high prevalence and limited therapeutic options. Heart failure is classified ...